Thomas E Burkey
Dr. Burkey is a nonruminant nutritionist with training in animal nutrition, digestive physiology and mucosal immunity. His interests include applying applied and basic techniques to investigate the complex interactions between nutrients, gut microbes, and immunity and how these interactions affect complex physiological traits important in domestic livestock species. As a graduate student at Kansas State University, Dr. Burkey was involved in applied research evaluating the effects of dietary alternatives to growth promoting antibiotics in a salmonella challenge model and basic research evaluating the effects of pathogenic bacteria on immune genes in vitro in a porcine intestinal epithelial cell line. Currently, at the University of Nebraska, Dr. Burkey’s research is focused in two main areas: 1) Characterization of the metabolic impact immune system activation and disease has on a growing pig’s metabolism and growth; and 2) Evaluating the in vivo and in vitro effects of pre- and probiotics on growth, immunity and nutrient transport.
Dr. Calvert received a Ph.D. in Genetics from Purdue University in 1988. After completing postdoctoral fellowships at the University of Guelph and at the USDA’s Avian Disease and Oncology Lab in East Lansing Michigan, he joined SmithKline Beecham Animal Health in 1994 and Pfizer Animal Health in 1995. He has been conducting PRRS research for 18 years with emphasis on vaccines, infectious clones, vectors, and receptors.
Scott Dee directs the research program at the Pipestone Veterinary Clinic and the Pipestone System. The Pipestone Veterinary Clinic has 24 veterinarians, 14 of which practice swine medicine, several with graduate degrees and/or board certification. The Pipestone System has approximately 170,000 sows making it one of the largest pork production systems in the US. The Pipestone research effort encompasses 3 R&D facilities, and > 40 sow farms. Its goal is to partner with key collaborators across the animal health industry in order to develop scientifically-sound data to enhance on-farm decision making.
The Faaberg laboratory, located at the National Animal Disease Center - Agricultural Research Service of the USDA, studies the molecular basis of PRRSV pathogenesis through the construction of viral infectious clones and infectious clone chimeras, as well as through examination of individual PRRSV proteins in various expression models. The laboratory also participates in studies examining the pathogenic effects of PRRSV field isolates and engineered viruses in swine.
After graduating from the Ontario Veterinary College at the University of Guelph in 1988, Dr. Harding worked in a mixed animal practice in Humboldt, Saskatchewan. He has specialized in swine since 1991, and in 1997 established a swine consultancy practice Harding Swine Veterinary Service. In 1997 he also completed a Master of Science degree in Veterinary Medicine, at the University of Minnesota. Dr. Harding has consulted for both small family and large corporate swine operations in Western Canada. He accepted a faculty position in Swine Production Medicine at the Western College of Veterinary Medicine, University of Saskatchewan in 2004, and was promoted to full professor in 2012. His research interests include emerging and re-emerging diseases, including Brachyspira colitis, periweaning failure-to-thrive syndrome (PFTS), reproductive PRRS, and porcine circovirus. In addition, his team is investigating prenatal immunologic programming associated with fetal uterine growth retardation. Dr. Harding is a frequent speaker at both domestic and international swine meetings, was the recipient of the A.D. Leman Science in Practice Award in 1999, the Pfizer Carl J. Norden Distinguished Teaching Award in 2009, and the Pfizer Animal Health Award for Research Excellence in 2010. He was the founding President of the Canadian Association of Swine Veterinarians from 2004-2005, Vice-President of the IPVS 2010 Congress in Vancouver, and is the Scientific Program Chair of the Western Canadian Association of Swine Veterinarians (WCASV). He has reviewed submissions for a number of peer-reviewed veterinary journals and granting agencies. In 2008 he became a Diplomate of the American Board of Veterinary Practitioners’ in the Swine Health Management specialty. In his spare time he enjoys outdoor activities including skiing, sailing, canoeing, hiking and woodworking.
Dick Hesse is the director of diagnostic virology at the Kansas State's Veterinary Diagnostic Laboratory in the College of Veterinary Medicine and is a professor of diagnostic medicine and pathobiology.
Hesse received his master's from South Dakota State University, with a focus on bovine respiratory viruses, and his doctorate from the University of Nebraska, with a focus on porcine rotavirus. He has authored or co-authored more than 70 publications, presentations and/or patents. In addition, he has led the development of at least 12 U.S. Department of Agriculture-licensed vaccines.
His many honors include: the Army Distinguished Service Medal for Lassa Fever research, membership in the Gamma Sigma Delta honor society, the Phi Zeta Honor Society of Veterinary Medicine, the Schering Plough Excellence Award for development of a porcine respiratory and reproductive syndrome vaccine, and the Kansas Veterinary Medical Association Distinguished Service Award.
Hesse's scientific career began during his undergraduate education when he assisted in college laboratories as well as at a local medical center. He expanded his laboratory experiences while in the U.S. Army, serving at USAMRIID, the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick, Md., where he worked with highly hazardous pathogens in total containment facilities, biosafety level 4.
After leaving the army, Hesse immediately began graduate studies with a focus on bovine respiratory viruses at South Dakota State University. The bulk of his career has involved research and development of animal vaccines in the private sector. He obtained his doctoral degree early in his career while employed by an animal health company and has continued to lead research related to infectious disease pathogenesis and vaccine development. Hesse's most recent focus has been on vaccine development for PRRS, porcine respiratory and reproductive syndrome and PCVAD, porcine circovirus-associated disease. He currently is developing rapid diagnostic assays and vaccines for zoonotic, foreign animal and emerging/re-emerging diseases.
Dr. Derald Holtkamp is an associate professor in the Department of Veterinary Diagnostics and Production Animal Medicine (VDPAM) in the College of Veterinary Medicine at Iowa State University (Ames, Iowa US). Dr. Holtkamp received his DVM, MS in Economics and BS in Agricultural Business with a minor in statistics all from Iowa State University. Prior to joining Iowa State he was a private veterinary consultant. He has also served as a technical services veterinarian for ADViSYS Inc., a biotechnology company based in Houston, Texas, Vice President of Swine Applications for MetaFarms Inc. and Director of Pork Development for E-Markets, Inc., both information technology companies based in Eagan, Minnesota and Ames, Iowa and as a swine veterinarian and service manager for Smithfield Foods in Warsaw, North Carolina. Dr. Holtkamp’s research focuses on the economics and risk management of swine disease with an emphasis on PRRS. He is directing the development of the Production Animal Disease Risk Assessment Program (PADRAP) at Iowa State University focusing on development, management and promotion of disease risk assessment tools and databases of completed risk assessments held by the American Association of Swine Veterinarians. He has authored or co-authored 17 publications in peer review journals over 70 proceedings articles. He is an active speaker in the US and internationally with over 100 presentations since 2006.
Dr. Johnson is a 2008 graduate from the University of Illinois College of Veterinary Medicine and is currently employed by The Maschhoffs as the Director of Health. His current responsibilities include leading a team of 20 internal and consulting veterinarians accountable for developing and implementing a strategy for systems-based animal health within The Maschhoffs' pig production system consisting of 200,000 sows and 4.5 million pigs marketed annually.
Dr. Tim Loula is a graduate of the University of Minnesota, College of Veterinary Medicine. He is co-founder and co-owner of SwineVetCenter, an exclusively swine veterinary practice in St. Peter, Minnesota which employs 10 veterinary consultants.
Dr. Loula has done consulting work in 33 U.S. states and 30 foreign countries. He received the American Association of Swine Veterinarians “Swine Practitioner of the Year” award in 1990 and was president of that organization in 1992-1993. He received the University of Illinois Executive Veterinary Program certificate in 1995. Dr. Loula was also awarded the 2001 Allen D. Leman Science in Practice Award and was selected as a 2009 Master of the Pork Industry by National Hog Farmer Magazine. He has delivered prestigious lectures throughout his career including the Howard Dunne Lecture for the 2008 annual meeting of the AASV, the Hansen and Kernkamp lectures for Allen D. Leman Swine Conferences in 1996 and 2009 respectively, the Jack Anderson lecture for KSU Swine Profitability Conference in 1996 and a keynote lecture at the 2008 IPVS conference.
Dr. Loula and the SwineVetCenter work closely with swine producers to improve production and herd health status while maintaining profitability. SwineVetCenter is also a leader in conducting practical swine research with four separate 2400-head research barn facilities.
Rodger Main, DVM, Ph.D.
Rodger has been serving as the Director of the Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL) for the past 5 years. The ISU-VDL consists of a team of 25 faculty members and 95 technical staff aimed at advancing its tripartite mission of service, teaching, and applied research in food supply medicine. Prior to coming to the ISU-VDL, Rodger had been serving as the Director Production Systems for Murphy-Brown’s Western Operations Hog Production Group where his responsibilities included coordinating herd health programs, leading production research and associated production system improvement initiatives, and directing multiplication functions.
Dr. X.J. Meng is a University Distinguished Professor at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech. Meng received his medical degree in China, and his Ph.D. degree in Immunobiology from Iowa State University College of Veterinary Medicine in Ames, Iowa. Prior to joining the faculty at Virginia Tech in 1999, Meng was a senior staff scientist at the National Institute of Allergy and Infections Diseases at NIH in Bethesda, MD. Dr. Meng’s research focuses on molecular mechanisms of pathogenesis and vaccine developments against emerging, re-emerging and zoonotic viruses of veterinary and human public health significance. Dr. Meng has published more than 255 peer-reviewed scientific papers, reviews and book chapters. According to Thompson Scientific’s ISI Essential Science Indicators, Dr. Meng is ranked in the top 1% highly-cited scientists in the world in the field of Microbiology based on total citations from 1997 to 2007. Dr. Meng’s publications have been cited for more than 12,349 times with a h-index of 61 according to Google Scholar Citation Record as of August 2013. Dr. Meng is an inventor for more than 35 awarded and pending patents on various virus vaccines and diagnostics. For example, Dr. Meng is the lead inventor of the Zoetis’s commercial PCV2 vaccine, Fostera™ PCV. Dr. Meng is the recipient of more than 27 national and international awards and honors such as the 2001 and 2007 Pfizer Award for Research Excellence, Honorary Diplomat of the American College of Veterinary Microbiologists, and elected fellow of the American Academy of Microbiology. Dr. Meng currently serve as an Editor for mBio, Animal Health Research Reviews, and PloS One, and also serve son the Editorial Boards for a number of other journals including Virus Research, Veterinary Microbiology, and Emerging Microbes and Infections. Dr. Meng has served in leadership positions for many international and national organizations and committees such as chair of the NIH Special Emphasis Panel IDM-B (15), chair of Hepatitis Review Section of the U.S. Military Infectious Diseases Research Program Annual Reviews, chair of the USDA-ARS National Program NP103 Panel I-Swine-2011, chair of International PRRS Symposium, and chair of the USDA NC-229 Committee. Dr. Meng currently teaches Molecular Virology (course leader), Emerging Infectious Diseases I and II (course leader), and Veterinary Virology (course instructor) courses at Virginia Tech.
His scientific journey began at the University of Notre Dame, where George Craig in the Department of Biology channeled his love of science in the direction of entomology. After graduating with a BS degree in biology in 1973, he joined the Peace Corps and served two years in Maracay, Venezuela, at the Centro Nacional de Investigaciones Agropecuarias, where he carried out research on non-insecticidal methods of pest control for yield improvement in maize. During this time, he amassed a collection of about 12,000 insects, and traveled throughout Venezuela and South America, thus developing an appreciation for the evolutionary diversity of insects and the cultural diversity of humans. He entered the entomology PhD program at Ohio State University in 1976 and left in 1980 with a dissertation on the regulation of egg laying in the house cricket, Acheta domestica, under the guidance of David Denlinger, who was recently elected to the National Academy of Science, two children, and awareness that a deeper knowledge of cell biology was needed to understand biological regulatory mechanisms. A postdoc appointment in the Department of Medicine, University of Texas Medical Center at Houston, filled this gap in knowledge. Working with Peter J.A. Davies, he became an expert in the regulation of transglutaminase expression in macrophages and dipped a toe into molecular biology. He joined the faculty of the Department of Veterinary Pathobiology at the University of Minnesota in 1985 as the token molecular biologist. With no veterinary background whatsoever, his chair, Victor Perman, asked only that he develop a research program that had something to do with animal health. This sage advice, combined with an energetic and ambitious faculty group in swine medicine and a supportive state swine industry, led him to develop a program in molecular mechanisms of disease resistance, focused on pigs, that has guided the lab for the following quarter century.
In the late 1980’s there were few reagents available to investigate porcine immunology, so the first challenge was to use the new power of recombinant DNA technology to clone, express, and purify cytokines. It was a fertile time for a molecular biologist, even one who had never done a Southern blot, in a College of Veterinary Medicine. Papers were published describing cytokine biology in swine, molecular diagnostic tools for bacterial pathogens, and collaborative research in neurobiology, pharmacology, and related topics. Studies in porcine pleuropneumonia showed that In 1990, a new viral disease of swine emerged simultaneously in North America and Europe. Porcine reproductive and respiratory syndrome virus was, and remains still, a devastating disease of swine. The lab became involved in molecular analysis and evolution of PRRSV and has made extensive basic and translational contributions to the understanding of porcine immune responses to PRRSV. He was the director of the PRRS Coordinated Agricultural Project, the first USDA program project, from 2004 to 2008 and has lectured extensively on PRRS immunology, vaccinology, and diagnostics throughout the world. Recently his lab has initiated a similar program to elucidate the immunological interaction of swine with porcine circoviruses, and has contributed to annotation of immune response genes in the porcine genome.
In addition to maintaining an active research program that provides a home to undergraduates, graduate students, postdocs, and visiting scientists, he provides community outreach with molecular biotechnology workshops for educators, professionals, and international scientists, directs the Comparative and Molecular Biosciences graduate program, and regularly reviews grants and manuscripts. His many contributions have been recognized through the CVM Pfizer Award for Research Excellence (four times) and the University of Minnesota Inventor Recognition Award in 2005, a University Innovations Award in 2011, and the Allen D. Leman Swine Conference Pijoan Lectureship in 2008.
Dr. Polson received his DVM from Iowa State University in 1982, then practiced in a predominantly swine practice in Iowa until 1987. He then entered the Integrated Food Animal Management program at the University of Illinois and received his MS in 1989. Dr. Polson received his PhD from the University of Minnesota in 1996, focusing on applied epidemiology and production economics. In 1993 Dr. Polson joined NOBL Laboratories, which became the Swine Segment of Boehringer-Ingelheim Vetmedica.
Raymond “Bob” Rowland is a professor in the Diagnostic Medicine and Pathobiology department of Kansas State University’s College of Veterinary Medicine. Dr. Rowland’s current research interests center on addressing fundamental problems in infectious diseases caused by emerging pig viruses. The current focus is on molecular mechanisms of diseases caused by porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2). Related research includes the design and development of novel detection and vaccine approaches, as well as the control of PRRS in the field. This research has contributed to several publications and review articles.
Dr. Rowland’s research is supported by funding from United States Department of Agriculture (USDA), National Institutes of Health (NIH), Department of Homeland Security (DHS), the National Pork Board (NPB) and various other entities. Besides research, Dr. Rowland is actively involved in the training of graduate, undergraduate and DVM students. He teaches introductory lectures in veterinary virology for DVM students and is the coordinator of the DVM/PhD dual degree program in the College of Veterinary Medicine.
Dr. Rowland is co-director of the PRRS Host Genetics Consortium (PHGC), a multi-year project devoted to understanding the genetics of the interaction between PRRSV and the pig host. Other research-related activities include executive director of the PRRS Symposium.
Dr. Rowland received a Ph.D. in microbiology in 1989 from the University of New Mexico School of Medicine in Albuquerque. He was a postdoctoral fellow from 1989 to 1994 at the University of Minnesota, Minneapolis, in the laboratory of arteriviologist, Peter Plagemann. He then joined the faculty at South Dakota State University in Brookings. He joined Kansas State University in 2001.
Dr. Rowland can be reached via e-mail at email@example.com
Dr. Veit received a Ph.D. in Biology from Justus Liebig University in Giessen (Germany) in 1990 under the supervision of Prof. Rudolf Rott and Prof. Hans-Dieter Klenk. He pursued his post-doctoral training at the Free University of Berlin (Institute of Virology, Prof. Schmidt) and at the Sloan-Kettering Institute (Cellular Biochemistry and Biophysics Program, Prof. James E Rothman) in New York City. Since 1996 he is principal investigator at the Veterinary Faculty of the Free University Berlin where he received his habilitation in Biochemistry and Virology in 2003.
Dr. Veit has published 53 research papers and 17 review and book chapters. His research interest includes the cell biology of enveloped viruses, especially Influenza viruses and more recently also Arteriviruses. His current focus is on the structure, processing, vesicular transport and membrane interactions of viral glycoproteins and their function during virus entry and budding.
Dr. Yoo studied Veterinary Medicine at Seoul National University, Korea. He completed his Master of Science degree in microbiology at the same institution and moved to Canada for further studies in virology at the University of Ottawa. His doctoral advisor, Dr. Kang, was a virologist trained in the laboratory of Dr. H. Temin who received the Nobel Prize for the 'provirus' hypothesis which led to the discovery of reverse transcriptase. Dr. Yoo's doctoral research involved molecular investigation of the hantavirus genome. Dr. Yoo pursued his post-doctoral training at Vaccines and Infectious Disease Organization under the supervision of Dr. L.A. Babiuk, who now serves as Vice-President for Research at the University of Alberta. Dr. Yoo was initially appointed professor at the University of Guelph in Canada and later moved to join the University of Illinois at Urbana-Champaign in the USA.
Dr. Yoo's career in research is unique as his training and education has taken place in a medical and veterinary setting. His research strengths lie in molecular virology and pathogenic mechanism, which serves to form the basis of his current research themes and direction. Dr. Yoo uses Porcine Reproductive and Respiratory Syndrome (PRRS) virus as a model to study cell-virus interactions and to understand viral evasion strategies against host immune surveillance. Dr. Yoo has been studying to understand the modulation of type I interferon responses by PRRS virus during infection. Dr. Yoo has developed a reverse genetics system, and using this system he is able to generate genetically engineered mutant viruses. This tool enables to study various pathogenic mechanisms and to investigate the role that individual viral proteins play during infection.
Dr. Zimmerman has enjoyed a position in the Veterinary Diagnostic Laboratory at Iowa State University since 1990. He has published extensively on swine health, with ~110 refereed publications, 13 book chapters, and co-editorship of Diseases of Swine (9th and 10th editions). His current focus is on the adaptation of PCR- and antibody-based diagnostic assays to pig oral fluid samples and their use for surveillance in swine populations. More broadly, his research interests include epidemiology, disease ecology, and the development of cost-effective methods to monitor, quantify, and ameliorate the effect of pathogens on swine health in pig farms.